Headlines

NutraCast: Why Ayana Bio CEO Frank Jaksch is betting on synbio

NutraCast: Why Ayana Bio CEO Frank Jaksch is betting on synbio

Synthetic biology technologies make it possible to create just about anything sustainably – including plants and fungal bioactives. Synbio has become a disruptive force that a growing number of companies are leaning into, including plant cell tech startup and Ginkgo Bioworks spinoff Ayana Bio. At the helm of the company is Frank Jaksch, who previously spent over two decades leading publicly-traded ingredient company ChromaDex.

Global Industry News

News

Trends

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers